
    
      The pilot study will be conducted in two mental health centers. In order to examine our
      hypothesis, we will use an add-on design. Into the study will be enrolled 50 patients with
      schizophrenia and schizoaffective disorder (males and females, 19-60 years old), according to
      the DSM-IV criteria, treated with clozapine and suffering from hypersalivation.
    
  